People: Eisai Co Ltd (4523.T)

4523.T on Tokyo Stock Exchange

1:25am EDT
Price Change (% chg)

¥-12 (-0.30%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Search Stocks

Kai, Yasunobu 

Brief Biography

Mr. Yasunobu Kai has been serving as Executive Officer, President of Eisai Japan Oncology hhc Unit and Director of Oncology Medical Division in Eisai Co., Ltd. since April 2013. He joined the Company in April 1986. He used to be President of Frontier Drug Development Unit and President of Eisai Value Maximization Systems.

Basic Compensation

Total Annual Compensation, Long-Term Incentive Plans, All Other, Fiscal Year Total,
-- -- -- --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Search Stocks